Finanzwire Finanzwire
Basculer en Français
9629 Companies
191458 Keywords
122917 Articles
102032 Press releases
Headlines Articles Press releases Science&Humans Remove
  1. Home
  2. Companies
  3. Science&Humans
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/23/2024 at 13:10, 1 year 3 months ago

    Science & Humans Appoints Karim "Matt" Nassar as Chief Growth Officer

    Digital Pharmacy Chief Growth Officer Karim Nassar Science & Humans Hormone Health
  • PRESS RELEASE

    published on 09/23/2024 at 13:05, 1 year 3 months ago

    Science & Humans Proudly Welcomes Renowned Healthcare Leader Karim "Matt" Nassar as Chief Growth Officer

    Science & Humans appoints Karim (Matt) Nassar as the Chief Growth Officer to lead the expansion of its direct-to-consumer hormone health program to private payers. Matt's expertise positions S&H to be a leader in the healthy aging sector
    Chief Growth Officer Karim Nassar Science & Humans Hormone Health Healthy Aging
    Logo of Science&Humans
  • PRESS RELEASE

    published on 09/19/2023 at 06:00, 2 years 3 months ago

    Jump for Menopause: Science&Humans Spreads its Wings for Over 100 Million Women Across North America During Menopause Awareness Month this October

    Logo of Science&Humans
  • PRESS RELEASE

    published on 09/07/2023 at 15:00, 2 years 4 months ago

    Jump for Menopause: Science&Humans Spreads its Wings for Over 100 Million Women across North America during Menopause Awareness Month this October

    Logo of Science&Humans
Accesswire
  • Published on 01/10/2026 at 05:10, 1 day 18 hours ago

    Sekur Private Data Ltd. Announces Non-Brokered Private Placement

  • Published on 01/10/2026 at 00:45, 1 day 22 hours ago

    Digi Power X Announces Entry into Settlement Agreement

  • Published on 01/09/2026 at 23:30, 2 days ago

    Sun Peak Metals Grants Stock Options

  • Published on 01/09/2026 at 23:30, 2 days ago

    Matador Technologies Announces Grant of Restricted Share Units to Management Team

  • Published on 01/09/2026 at 23:10, 2 days ago

    Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction

View all ACCESSWIRE
EQS Group
  • Published on 01/11/2026 at 22:20, 1 hour 12 minutes ago

    Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

  • Published on 01/10/2026 at 21:25, 1 day 2 hours ago

    CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh

  • Published on 01/10/2026 at 13:05, 1 day 10 hours ago

    SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation

  • Published on 01/09/2026 at 21:55, 2 days 1 hour ago

    Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)

  • Published on 01/09/2026 at 18:36, 2 days 4 hours ago

    Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS
Les Echos
  • Published on 01/09/2026 at 18:30, 2 days 5 hours ago

    H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm

  • Published on 01/09/2026 at 17:45, 2 days 5 hours ago

    January 2026

  • Published on 01/09/2026 at 17:45, 2 days 5 hours ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

  • Published on 01/09/2026 at 17:42, 2 days 5 hours ago

    Aéroports de Paris SA - Shares and voting rights as of 31 December 2025

  • Published on 01/08/2026 at 21:00, 3 days 2 hours ago

    Biannual report on SEB S.A.’S liquidity agreement

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy